Le Lézard
Classified in: Health
Subjects: WOM, PLW, DEI

ALASTIN Skincare® Announces Issuance Of Fifth And Sixth U.S. Patent Incorporating Revolutionary TriHex Technology®


CARLSBAD, Calif., Oct. 6, 2021 /PRNewswire/ -- ALASTIN Skincare®, Inc. - a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care products, announces that the United States Patent and Trademark Office has issued two new patents, bringing the total number of ALASTIN U.S. patents to six, along with a seventh patent issued in Canada. U.S. Patent No.11,052,032 covers ALASTIN's platform TriHex Technology® and US Patent No. 11,103,455 relates to liposomal compositions, both associated with TransFORM Body Treatment. These new patents are directed to methods for the use of topical compositions of TransFORM Body Treatment with TriHex Technology® to improve skin laxity, texture or crepiness, with or without body contouring procedures or for targeting dermal white adipose tissue.

"We are immensely proud of the scientific rigor we have established in validating the TriHex Technology performance in our product formulations, which is confirmed by our numerous patents," commented Dr. Alan Widgerow, MBBCh (MD); MMed (MHS); FCS; FACS and Chief Medical Officer at ALASTIN. "This is particularly relevant to this TransFORM Body product where disruptive new science has allowed us to make great progress in aiding skin tightening and body contouring."

Award-winning TransFORM Body Treatment with TriHex Technology was launched in 2018 and has been recognized for its demonstrated clinical efficacy, both as a complement to popular non-invasive body contouring procedures to support the body's natural repair processes, and on its own for its proven skin smoothing effects.

Visit www.alastin.com to find a physician retailer near you.

About ALASTIN Skincare®, Inc.
ALASTIN Skincare® is dedicated to developing innovative, clinically-tested skin care products that correct, protect and maintain healthy skin for a lifetime. Our unparalleled Procedure Enhancement and Restore & Renew products are formulated with our TriHex Technology®, a patented combination of key peptides and other synergistic ingredients using the latest technology and are clinically tested to demonstrate safety and their ability to help reawaken the skin's youthful regenerating processes.

@AlastinSkincare
#AlastinSkincare

SOURCE ALASTIN Skincare


These press releases may also interest you

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...



News published on and distributed by: